Let's Talk About MRD

https://youtu.be/SyzrR35sNTY

Measurable Residual Disease (MRD) negativity is extremely important to myeloma patients because it measures whether myeloma cells are still detectable in a patient following their treatment. If a patient’s treatment is optimally effective and MRD negativity is achieved, a patient’s progression-free survival (PFS) can improve significantly!

Click HERE to read more about MRD negativity.